• Vol. 43 No. 6, 294–295
  • 15 June 2014

Blood Stem Cell Donation: A Model for Worldwide Cooperation in Transplantation

155



155 Views
26 Downloads

Download PDF

Haematopoietic stem cell transplantation (HSCT) has been carried out for more than 50 years in over 50 countries. Over a million patients have undergone this procedure, giving hope and a new lease of life to many patients with otherwise incurable or high-risk blood-related cancers and other diseases. The procedure involves taking good blood stem cells from an individual and giving them to a patient who has just received a preparative regimen of high dose chemotherapy and/or radiation. These blood stem cells may be autologous if they are derived from the patient himself or allogeneic if obtained from another individual. While a human leukocyte antigen (HLA) matched sibling is the first choice as a donor of these blood stem cells, only a quarter of patients have a suitable and matched sibling donor, and an unrelated or mismatched donor may need to be used.

This article is available only as a PDF. Please click on “Download PDF” on top to view the full article.